Abstract
Background & Aims: We conducted a systematic review with meta-analysis to estimate rates and trends of colectomy in patients with ulcerative colitis (UC), and of primary and re-resection in patients with Crohn's disease (CD), focusing on contemporary risks. Methods: Through a systematic review until September 3, 2019, we identified population-based cohort studies that reported patient-level cumulative risk of surgery in patients with UC and CD. We evaluated overall and contemporary risk (after 2000) of surgery and analyzed time trends through mixed-effects meta-regression. Results: In patients with UC (26 studies), the overall 1-, 5-, and 10-year risks of colectomy was 4.0% (95% CI, 3.3–5.0), 8.8% (95% CI, 7.7–10.0), and 13.3% (95% CI, 11.3–15.5), respectively, with a decrease in risk over time (P <.001). Corresponding contemporary risks were 2.8% (95% CI, 2.0–3.9), 7.0% (95% CI, 5.7–8.6), and 9.6% (95% CI, 6.3–14.2), respectively. In patients with CD (22 studies), the overall 1-, 5-, and 10-year risk of surgery was 18.7% (95% CI, 15.0–23.0), 28.0% (95% CI, 24.0–32.4), and 39.5% (95% CI, 33.3–46.2), respectively, with a decrease in risk over time (P <.001). Corresponding contemporary risks were 12.3% (95% CI, 10.8–14.0), 18.0% (95% CI, 15.4–21.0), and 26.2% (95% CI, 23.4–29.4), respectively. In a meta-analysis of 8 studies in patients with CD with prior resection, the cumulative risk of a second resection at 5 and 10 years after the first resection was 17.7% (95% CI, 13.5–22.9) and 31.3% (95% CI, 24.1–39.6), respectively. Conclusions: Patient-level risks of surgery have decreased significantly over time, with a 5-year cumulative risk of surgery of 7.0% in UC and 18.0% in CD in contemporary cohorts. This decrease may be related to early detection and/or better treatment.
Original language | English (US) |
---|---|
Pages (from-to) | 2031-2045.e11 |
Journal | Clinical Gastroenterology and Hepatology |
Volume | 19 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2021 |
Funding
Funding Supported by an American Gastroenterological Association Career Development Award (P.S.D.), a National Institute of Diabetes and Digestive and Kidney Diseases–funded San Diego Digestive Diseases Research Center (P30 DK120515) (W.J.S.), National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (K23DK117058), an American College of Gastroenterology Junior Faculty Development Award (144271), and a Crohn's and Colitis Foundation Career Development Award (404614) (S.S.).
Keywords
- Disease Modification
- Inflammatory Bowel Diseases
- Natural History
- Resection
- Tumor Necrosis Factor
ASJC Scopus subject areas
- Hepatology
- Gastroenterology